EIX
39
2
INTU
67
-2
CTAS
50
-2
EXPE
56
2
BBY
36
-4
APA
46
-3
FDX
47
-3
AIG
39
-12
MDT
57
-2
CCI
28
3
CNX
45
3
DE
58
2
GOOG
65
2
AMZN
56
-2
GD
46
-3
MAS
40
-11
DG
42
-4
ALL
38
-12
KEY
41
4
AMAT
58
-3
EIX
39
2
INTU
67
-2
CTAS
50
-2
EXPE
56
2
BBY
36
-4
APA
46
-3
FDX
47
-3
AIG
39
-12
MDT
57
-2
CCI
28
3
CNX
45
3
DE
58
2
GOOG
65
2
AMZN
56
-2
GD
46
-3
MAS
40
-11
DG
42
-4
ALL
38
-12
KEY
41
4
AMAT
58
-3
Financhill
Back

ALPS Medical Breakthroughs ETF Stock Predictions

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
60

SBIO
ALPS Medical Breakthroughs ETF

Last Price:
$30.61
Seasonality Move:
5.55%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

ALPS Medical Breakthroughs ETF Stock Forecast

  • Over the next 52 weeks, ALPS Medical Breakthroughs ETF has on average historically risen by 2.5% based on the past 10 years of stock performance.
  • ALPS Medical Breakthroughs ETF has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is ALPS Medical Breakthroughs ETF Stock Undervalued?
    The current ALPS Medical Breakthroughs ETF [SBIO] share price is $30.21. The Score for SBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ALPS Medical Breakthroughs ETF Stock Go Up Next Year?

  • Over the next 52 weeks, ALPS Medical Breakthroughs ETF has on average historically risen by 2.5% based on the past 10 years of stock performance.

ALPS Medical Breakthroughs ETF Stock Rating

Buy
60
ALPS Medical Breakthroughs ETF (SBIO) is a Buy

Is ALPS Medical Breakthroughs ETF overpriced?

  • ALPS Medical Breakthroughs ETF has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

ALPS Medical Breakthroughs ETF Stock Price History

Is SBIO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SBIO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
42.73
52-Week Low:
22.33

Prediction Charts

Market Cap:
0
Price in USD:
30.21
Volume:
34.5K
Beta:
1.12

Technical Analysis

SMA50:
28.60
SMA100:
29.79
SMA200:
33.33
52-Wk Change:
-7.46%

Stock Predictions

  • Is ALPS Medical Breakthroughs ETF stock public?
    Yes, ALPS Medical Breakthroughs ETF is a publicly traded company.
  • What is the ALPS Medical Breakthroughs ETF stock quote today?
    The ALPS Medical Breakthroughs ETF stock price is 30.21 USD today.
  • How to buy ALPS Medical Breakthroughs ETF stock online?
    You can buy ALPS Medical Breakthroughs ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 28.94 29.13 29.17 28.60
Jun-2 29.53 30.07 30.07 29.23
Jun-3 30.49 30.84 31.06 30.34
Jun-4 30.97 30.93 31.20 30.92
Jun-5 30.91 31.02 31.15 30.49
Jun-6 31.51 31.59 31.67 31.38
Jun-9 31.95 31.35 31.95 31.12
Jun-10 31.39 31.76 31.91 31.39
Jun-11 31.98 31.19 31.98 31.19
Jun-12 31.06 31.28 31.38 30.98
Jun-13 30.65 30.93 31.17 30.65
Jun-16 30.55 30.77 30.89 30.55
Jun-17 30.51 30.31 30.65 30.24
Jun-18 30.23 30.21 30.61 30.10

ALPS Medical Breakthroughs ETF Earnings

Data Unavailable

ALPS Medical Breakthroughs ETF Forecast Revenue Growth

Data Unavailable

* ALPS Medical Breakthroughs ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.